Literature DB >> 17766918

Capitalizing on Mendelian randomization to assess the effects of treatments.

George Davey Smith1.   

Abstract

Mesh：

Year:  2007        PMID： 17766918      PMCID： PMC1963388          DOI： 10.1177/014107680710000923

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  36 in total

1.  Commentary: the concept of 'Mendelian Randomization'.

Authors:  Duncan C Thomas; David V Conti
Journal:  Int J Epidemiol       Date:  2004-02       Impact factor: 7.196

2.  Genetic variation and willingness to participate in epidemiologic research: data from three studies.

Authors:  Parveen Bhatti; Alice J Sigurdson; Sophia S Wang; Jinbo Chen; Nathaniel Rothman; Patricia Hartge; Andrew W Bergen; Maria Teresa Landi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

3.  C-reactive protein and its role in metabolic syndrome: mendelian randomisation study.

Authors:  Nicholas J Timpson; Debbie A Lawlor; Roger M Harbord; Tom R Gaunt; Ian N M Day; Lyle J Palmer; Andrew T Hattersley; Shah Ebrahim; Gordon D O Lowe; Ann Rumley; George Davey Smith
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

4.  Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk.

Authors:  K B Moysich; J L Freudenheim; J A Baker; C B Ambrosone; E D Bowman; E F Schisterman; J E Vena; P G Shields
Journal:  Mol Carcinog       Date:  2000-01       Impact factor: 4.784

5.  Apolipoprotein E isoforms, serum cholesterol, and cancer.

Authors:  M B Katan
Journal:  Lancet       Date:  1986-03-01       Impact factor: 79.321

6.  Osteoporosis, intestinal lactase deficiency and low dietary calcium intake.

Authors:  S J Birge; H T Keutmann; P Cuatrecasas; G D Whedon
Journal:  N Engl J Med       Date:  1967-02-23       Impact factor: 91.245

7.  Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.

Authors:  G Harrison; S Richards; S Lawson; P Darbyshire; R Pinkerton; R Stevens; A Oakhill; O B Eden
Journal:  Ann Oncol       Date:  2000-08       Impact factor: 32.976

8.  An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico.

Authors:  M R Garcia-Palmieri; P D Sorlie; R Costas; R J Havlik
Journal:  Am J Epidemiol       Date:  1981-07       Impact factor: 4.897

9.  Lactase deficiency: prevalence in osteoporosis.

Authors:  A D Newcomer; S F Hodgson; D B McGill; P J Thomas
Journal:  Ann Intern Med       Date:  1978-08       Impact factor: 25.391

10.  The apolipoprotein E epsilon4 allele is no risk factor for prostate cancer in the Norwegian population.

Authors:  N Wessel; K Liestøl; J Maehlen; S H Brorson
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640
View more
  16 in total

Review 1.  Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?

Authors:  Shah Ebrahim; George Davey Smith
Journal:  Hum Genet       Date:  2007-11-23       Impact factor: 4.132

2.  William Bateson, the rediscoverer of Mendel.

Authors:  Milo Keynes; T M Cox
Journal:  J R Soc Med       Date:  2008-03       Impact factor: 5.344

3.  Statistical Methods in Integrative Genomics.

Authors:  Sylvia Richardson; George C Tseng; Wei Sun
Journal:  Annu Rev Stat Appl       Date:  2016-04-18       Impact factor: 5.810

4.  Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration.

Authors:  Veronika W Skrivankova; Rebecca C Richmond; Benjamin A R Woolf; Neil M Davies; Sonja A Swanson; Tyler J VanderWeele; Nicholas J Timpson; Julian P T Higgins; Niki Dimou; Claudia Langenberg; Elizabeth W Loder; Robert M Golub; Matthias Egger; George Davey Smith; J Brent Richards
Journal:  BMJ       Date:  2021-10-26

5.  Genetic research and aboriginal and Torres Strait Islander Australians.

Authors:  Emma Kowal; Glenn Pearson; Lobna Rouhani; Chris S Peacock; Sarra E Jamieson; Jenefer M Blackwell
Journal:  J Bioeth Inq       Date:  2012-10-12       Impact factor: 1.352

6.  The druggable genome and support for target identification and validation in drug development.

Authors:  Chris Finan; Anna Gaulton; Felix A Kruger; R Thomas Lumbers; Tina Shah; Jorgen Engmann; Luana Galver; Ryan Kelley; Anneli Karlsson; Rita Santos; John P Overington; Aroon D Hingorani; Juan P Casas
Journal:  Sci Transl Med       Date:  2017-03-29       Impact factor: 17.956

7.  Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.

Authors:  Nichola Johnson; Paolo De Ieso; Gabriele Migliorini; Nick Orr; Peter Broderick; Daniel Catovsky; Athena Matakidou; Timothy Eisen; Christy Goldsmith; Frank Dudbridge; Julian Peto; Isabel Dos-Santos-Silva; Alan Ashworth; Gillian Ross; Richard S Houlston; Olivia Fletcher
Journal:  Cancer Res       Date:  2016-03-15       Impact factor: 12.701

8.  An experimental analysis of acquired impulse control among adult humans intolerant to alcohol.

Authors:  Jianxin Wang; Yulei Rao; Daniel E Houser
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-24       Impact factor: 12.779

Review 9.  Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2010-12-09       Impact factor: 4.162

10.  Why have tobacco control policies stalled? Using genetic moderation to examine policy impacts.

Authors:  Jason M Fletcher
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.752
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.